AF
KRON

Amalgamated Financial’s Kronos Bio KRON Stock Holding History

Amalgamated Financial’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$35K Buy
+4,910
New +$41.9K ﹤0.01% 2567

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Amalgamated Financial's KRON Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Kronos Bio (KRON) in Q1 2022: 4,910 shares worth $35K. The stake represents ﹤0.01% of the portfolio and ranks #2567 among its holdings.

96 funds tracked by Wall St. Rank hold KRON as of Q1 2022.

  • Amalgamated Financial held 4,910 shares of Kronos Bio worth $35K as of Q1 2022.
  • Kronos Bio was a new Amalgamated Financial position in Q1 2022.
  • Kronos Bio made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2567 holding.
  • 96 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.